ADMA: ADMA Biologics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,195.23
Enterprise Value ($M) 2,280.76
Book Value ($M) 153.71
Book Value / Share 0.66
Price / Book 14.28
NCAV ($M) 79.25
NCAV / Share 0.34
Price / NCAV 27.70

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.03

Liquidity (mrq)
Quick Ratio 1.86
Current Ratio 5.21

Balance Sheet (mrq) ($M)
Current Assets 276.42
Assets 350.88
Liabilities 197.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 258.21
Operating Income 24.43
Net Income -28.24
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 8.80
Cash from Investing -4.98
Cash from Financing -38.99

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-11 13G/A Nuveen Asset Management, LLC 2.17 -2.77
03-11 13G/A Tiaa Cref Investment Management Llc 2.17 -2.77
03-11 13G/A Teachers Advisors, Llc 2.17 -2.77
02-14 13G/A Perceptive Advisors Llc 2.80 -45.94
02-13 13G Vanguard Group Inc 5.71
01-26 13G/A BlackRock Inc. 7.90 18.65

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-24 319,290 2,112,986 15.11
2024-05-23 341,838 2,043,032 16.73
2024-05-22 249,744 829,611 30.10
2024-05-21 360,632 1,184,649 30.44
2024-05-20 374,889 1,232,919 30.41

(click for more detail)

Similar Companies
ACET – Adicet Bio, Inc. ACIU – AC Immune SA
ACRV – Acrivon Therapeutics, Inc. AFMD – Affimed N.V.
ALIM – Alimera Sciences, Inc.


Financial data and stock pages provided by
Fintel.io